Dashboard
Manage Tickers

CERTCertara, Inc.

Nasdaq certara.com


$ 16.44 $ -0.28 (-1.67 %)    

Wednesday, 24-Apr-2024 15:59:36 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.96 $ 1.44 (0.34 %)
DIA $ 384.57 $ -0.58 (-0.15 %)
SPY $ 502.89 $ -0.24 (-0.05 %)
TLT $ 88.37 $ -0.63 (-0.71 %)
GLD $ 214.61 $ -0.40 (-0.19 %)
$ 16.45
$ 16.71
$ 0.00 x 0
$ 0.00 x 0
$ 16.36 - $ 16.72
$ 11.81 - $ 24.70
421,470
na
2.61B
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-07-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-15-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

certara-shares-are-trading-higher-after-keybanc-upgraded-the-stock-from-sector-weight-to-overweight
Certara shares are trading higher after Ke...
04/10/2024 11:13:17

keybanc-upgrades-certara-to-overweight-announces-23-price-target
Keybanc Upgrades Certara to Overweight, An...
04/10/2024 08:38:49

Keybanc analyst Scott Schoenhaus upgrades Certara (NASDAQ:CERT) from Sector Weight to Overweight and announces $23 price tar...

decoding-4-analyst-evaluations-for-certara
Decoding 4 Analyst Evaluations For Certara
04/04/2024 12:01:43

jmp-securities-initiates-coverage-on-certara-with-market-perform-rating
JMP Securities Initiates Coverage On Certa...
04/04/2024 08:54:21

JMP Securities analyst Constantine Davides initiates coverage on Certara (NASDAQ:CERT) with a Market Perform rating.

ubs-maintains-neutral-on-certara-raises-price-target-to-20
UBS Maintains Neutral on Certara, Raises P...
03/01/2024 16:38:11

UBS analyst Dan Leonard maintains Certara (NASDAQ:CERT) with a Neutral and raises the price target from $17 to $20.

analyst-scoreboard-4-ratings-for-certara
Analyst Scoreboard: 4 Ratings For Certara
03/01/2024 16:00:59

jefferies-maintains-hold-on-certara-raises-price-target-to-155
Jefferies Maintains Hold on Certara, Raise...
03/01/2024 12:23:05

Jefferies analyst David Windley maintains Certara (NASDAQ:CERT) with a Hold and raises the price target from $14 to $15.5.

certara-sees-2024-adj-eps-041-046-vs-048-est-revenue-385m-400m-vs-36395m-est
Certara Sees 2024 Adj. EPS $0.41-$0.46 vs ...
02/29/2024 21:12:14

certara-q4-2023-adj-eps-0090-misses-0110-estimate-sales-88m-beat-86596m-estimate
Certara Q4 2023 Adj EPS $0.090 Misses $0.1...
02/29/2024 21:11:17

Certara (NASDAQ:CERT) reported quarterly earnings of $0.090 per share which missed the analyst consensus estimate of $0.110 by ...

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

leerink-partners-initiates-coverage-on-certara-with-market-perform-rating-announces-price-target-of-19
Leerink Partners Initiates Coverage On Cer...
02/26/2024 13:36:49

Leerink Partners analyst Michael Cherny initiates coverage on Certara (NASDAQ:CERT) with a Market Perform rating and announc...

tax-season-is-here-meet-the-new-federal-program-that-can-eat-away-at-tax-preparation-companies
Tax Season Is Here: Meet The New Federal P...
01/30/2024 19:31:06

New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop ...

barclays-maintains-equal-weight-on-certara-raises-price-target-to-18
Barclays Maintains Equal-Weight on Certara...
01/25/2024 14:43:43

Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and raises the price target from $16 to $18.

certara-acquires-applied-biomath-no-terms-disclosed
Certara Acquires Applied BioMath; No Terms...
12/13/2023 21:32:26

ubs-initiates-coverage-on-certara-with-neutral-rating-announces-price-target-of-17
UBS Initiates Coverage On Certara with Neu...
12/07/2023 11:09:14

UBS analyst Dan Leonard initiates coverage on Certara (NASDAQ:CERT) with a Neutral rating and announces Price Target of $17.

keybanc-initiates-coverage-on-certara-with-sector-weight-rating
Keybanc Initiates Coverage On Certara with...
12/05/2023 11:18:11

Keybanc analyst Scott Schoenhaus initiates coverage on Certara (NASDAQ:CERT) with a Sector Weight rating.

certara-introduces-simcyp-biopharmaceutics-software-to-increase-efficiency-of-novel-and-generic-drug-formulation--development
Certara Introduces Simcyp Biopharmaceutics...
11/21/2023 21:33:00

Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics sof...

certara-reiterates-fy23-adj-eps-044-048-vs-045-est-revenue-345m-360m-vs-3529m-est
Certara Reiterates FY23 Adj. EPS $0.44-$0....
11/08/2023 22:13:10

certara-q3-2023-adj-eps-011-inline-with-estimate-revenue-856m-misses-86245m-estimate
Certara Q3 2023 Adj. EPS $0.11 Inline With...
11/08/2023 21:44:30

recap-certara-q3-earnings
Recap: Certara Q3 Earnings
11/08/2023 21:15:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION